Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Theravance Biopharma, Inc. (TBPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 8-K Quarterly results
Docs: "Theravance Biopharma, Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update",
"MEDICINES THAT MAKE A DIFFERENCE"
06/09/2023 8-K Termination of a Material Definitive Agreement  Interactive Data
05/08/2023 8-K Quarterly results
Docs: "Theravance Biopharma, Inc. Reports First Quarter 2023 Financial Results and Provides Business Update",
"Slide deck entitled First Quarter 2023 Financial Results and Business Update"
05/03/2023 8-K Quarterly results
04/17/2023 8-K Quarterly results
03/13/2023 8-K Regulation FD Disclosure  Interactive Data
03/01/2023 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/28/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Continued Transformation Positions Theravance Biopharma for Value Creation"
02/27/2023 8-K Quarterly results
Docs: "Theravance Biopharma, Inc. Announces Strategic Actions and Reports Fourth Quarter / Full Year 2022 Financial Results and Business Update",
"Slide deck entitled Strategic Actions and Fourth Quarter / Full Year 2022 Financial Results and Business Update"
01/09/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Theravance Biopharma, Inc. Highlights 2022 Accomplishments and 2023 Key Targets",
"Slide deck entitled Theravance Biopharma Investor Presentation"
12/12/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/14/2022 8-K/A Quarterly results
11/07/2022 8-K Quarterly results
Docs: "Theravance Biopharma, Inc. Reports Third Quarter 2022 Financial Results, Provides Business Update and Extends Tender Offer",
"MEDICINES THAT MAKE A DIFFERENCE"
11/02/2022 8-K Quarterly results
09/20/2022 8-K Other Events  Interactive Data
09/19/2022 8-K Entry into a Material Definitive Agreement  Interactive Data
09/13/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Slide deck entitled Transformed and Focused on Medicines that Make a Difference®"
08/25/2022 8-K Other Events  Interactive Data
08/04/2022 8-K Quarterly results
07/20/2022 8-K Quarterly results
07/13/2022 8-K Quarterly results
07/13/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
04/28/2022 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
04/04/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Theravance Biopharma, Inc. Announces Results from Study 0170, a Second Phase 3 Study of Ampreloxetine, in Patients with Symptomatic Neurogenic Orthostatic Hypotension",
"Slide deck entitled Study 0170 (REDWOOD) Ampreloxetine Phase 3 Results"
02/23/2022 8-K Quarterly results
Docs: "Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update",
"Slide deck entitled Fourth Quarter and Full Year 2021 Financial Results and Business Update"
01/10/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Slide deck entitled JP Morgan Healthcare Conference",
"Slide deck entitled Appendix Slides to Investor Presentation"
12/22/2021 8-K Termination of a Material Definitive Agreement  Interactive Data
12/16/2021 8-K Other Events  Interactive Data
12/06/2021 8-K/A Quarterly results
11/16/2021 8-K Other Events  Interactive Data
11/03/2021 8-K Quarterly results
Docs: "Theravance Biopharma, Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update",
"Slide deck entitled Third Quarter 2021 Financial Results and Business Update"
10/05/2021 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Consulting Agreement between the Company and Bradford J. Shafer"
09/15/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy